19 results
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free ... Survival #EBM ... #Honc #Osimertinib ... NSCLC #Survival #NEJM
IgM and Non-IgM - Risk and Type of Progression #EBM #Honc #MGUS #Progression #IgM #NonIgM #MultipleMyeloma
Risk and Type of Progression ... #EBM #Honc #MGUS ... #Progression #IgM ... MultipleMyeloma #NEJM
Cumulative Incidence of Progression of MGUS, with Death Accounted for as a Competing Risk #EBM #Honc
Cumulative Incidence of Progression ... Competing Risk #EBM ... #Honc #MGUS #Progression ... #IgG #MGUS #NEJM
An AAV5 vector with a functional factor VIII gene tested in men with hemophilia A #EBM
hemophilia A #EBM ... #Honc #hemophilia ... VisualAbstract #NEJM
Eye Anatomy and Key Diagnoses Rule of 2s - Anterior Eye - Utilize slit lamp exam
exam #Diagnosis #EM ... #Ophth #Anterior ... AnteriorChamber #Lens #ALiEM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Lung Cancer - Progression-free ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Acute Angle Closure Glaucoma - Exam: Corneal edema, mid-dilated NON-reactive pupil #Clinical #EM #Ophth #SlitLamp #AngleClosure
pupil #Clinical #EM ... #Ophth #SlitLamp ... AngleClosure #Glaucoma #ALiEM
Pyogenic Granuloma of the Conjunctiva - A 30-year-old man presented with a pedunculated lesion on his
#Clinical #Ophth ... #EM #PyogenicGranuloma ... #Conjunctival #NEJM
Pembrolizumab Response Rate by Tumor Type #EBM #Honc #Pharm #Pembrolizumab #Response #TumorType #Colorectal #Endometrial #Biliary #NEJM
by Tumor Type #EBM ... #Honc #Pharm #Pembrolizumab ... Endometrial #Biliary #NEJM
Bacterial Conjunctivitis #Clinical #EM #Ophth #Bacterial #Conjunctivitis #BacterialConjunctivitis #ALiEM
Conjunctivitis #Clinical #EM ... #Ophth #Bacterial ... BacterialConjunctivitis #ALiEM